Journal of Bone and Mineral Metabolism

, Volume 26, Issue 1, pp 93–100 | Cite as

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

  • Masataka ShirakiEmail author
  • Tatsuhiko Kuroda
  • Shiro Tanaka
  • Mitsuru Saito
  • Masao Fukunaga
  • Toshitaka Nakamura


Advanced glycation end products (AGE) in collagen have been reported to decrease the mechanical property of bone. However, there are no available data on the relation between fracture risk and levels of glycoxidative (nonenzymatic) cross-links of collagen in clinical samples. A total of 432 Japanese elderly women who were not receiving any drug treatment for osteoporosis were selected and followed for 5.2 ± 3.3 (mean ± SD) years for this observational study. Vertebral fractures and bone mineral density were assessed at baseline and then at 1- to 2-year intervals or at indication of any symptom. Two types of collagen metabolites were measured at baseline: urinary N-terminal telopeptide of type I collagen (NTX), a marker of pyridinium cross-link, and urinary pentosidine, a nonenzymatic collagen cross-link produced by AGEs. A total of 97 incident vertebral fractures on 72 subjects were observed. Simple regression analysis using Cox's hazards model showed that log-transformed urinary NTX and pentosidine are significant risk factors for time-dependent incidence of vertebral fractures, in addition to the traditional risk factors (age, lumbar bone mineral density, and number of prevalent vertebral fractures). However, urinary excretion of pentosidine (hazard ratio, 1.33; 95% CI, 1.01–1.76, P = 0.04) was a significant predictor of incident vertebral fracture after adjustment for other traditional risk factors. The present data suggest that AGE-related collagen cross-link is a novel risk for vertebral fracture.

Key words

osteoporosis vertebral fracture collagen cross-link pentosidine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy2001Osteoporosis prevention, diagnosis, and therapyJAMA285785795CrossRefGoogle Scholar
  2. 2.
    Silverman, SL, Minshall, ME, Shen, W, Harper, KD, Xie, S 2001Health-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from Multiple Outcomes of Raloxifene Evaluation StudyArthritis Rheum4426112619PubMedCrossRefGoogle Scholar
  3. 3.
    Oleksik, A, Lips, P, Dawson, A, Minshall, ME, Shen, W, Cooper, C, Kanis, J 2000Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fracturesJ Bone Miner Res1513841392PubMedCrossRefGoogle Scholar
  4. 4.
    Kanis, JA, McCloskey, EV 1992Epidemiology of vertebral osteoporosisBone (NY)13S1S10Google Scholar
  5. 5.
    Center, JR, Nguyen, TV, Schneider, D, Sambrook, PN, Eisman, JA 1999Mortality after all major types of osteoporotic fracture in men and women: an observational studyLancet353878882PubMedCrossRefGoogle Scholar
  6. 6.
    Kado, DM, Browner, WS, Palermo, L, Nevitt, MC, Genant, HK, Cummings, SR 1999Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research GroupArch Intern Med15912151220PubMedCrossRefGoogle Scholar
  7. 7.
    Kanis, JA, Black, D, Cooper, C, Dargent, P, Dawson-Hughes, B, De Laet, C, Delmas, P, Eisman, J, Johnell, O, Jonsson, B, Melton, L, Oden, A, Papapoulos, S, Pols, H, Rizzoli, R, Silman, A, Tenenhouse, A 2002International Osteoporosis Foundation; National Osteoporosis Foundation. A new approach to the development of assessment guidelines for osteoporosisOsteoporos Int13527536PubMedCrossRefGoogle Scholar
  8. 8.
    Orimo, H, Hayashi, Y, Fukunaga, M, Sone, T, Fujiwara, S, Shiraki, M, Kushida, K, Miyamoto, S, Soen, S, Nishimura, J, Oh-hashi, Y, Hosoi, T, Gorai, I, Tanaka, H, Igai, T, Kishimoto, H 2001Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis: year 2000 revisionJ Bone Miner Metab19331337PubMedCrossRefGoogle Scholar
  9. 9.
    Garnero, P, Hausherr, E, Chapuy, MC, Marcelli, C, Grandjean, H, Muller, C, Cormier, C, Breart, G, Meunier, PJ, Delmas, PD 1996Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective StudyJ Bone Miner Res1115311538PubMedGoogle Scholar
  10. 10.
    van Daele, PL, Seibel, MJ, Burger, H, Hofman, A, Grobbee, DE, Van Leeuwen, JP, Brikenhager, JC, Pols, HA 1996Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam studyBr Med J312482483Google Scholar
  11. 11.
    Garnero, P, Sornay-Rendu, E, Claustrat, B, Delmas, PD 2000Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY studyJ Bone Miner Res1515261536PubMedCrossRefGoogle Scholar
  12. 12.
    Shiraki, M, Kuroda, T, Nakamura, T, Fukunaga, M, Hosoi, T, Orimo, H, Makino, K 2006The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research GroupJ Bone Miner Metab24219225PubMedCrossRefGoogle Scholar
  13. 13.
    Wang, X, Shen, X, Li, X, Agrawal, CM 2002Age-related changes in the collagen network and toughness of boneBone (NY)3117Google Scholar
  14. 14.
    Oxlund, H, Mosekilde, L, Ortoft, G 1996Reduced concentration of collagen reducible crosslinks in human trabecular bone with respect to age and osteoporosisBone (NY)19479484Google Scholar
  15. 15.
    Oxlund, H, Barckman, M, Ortoft, G, Andreassen, TT 1995Reduced concentration of collagen cross-links are associated with reduced strength of boneBone (NY)17365S371SGoogle Scholar
  16. 16.
    Zioupos, P, Currey, JD, Hamer, AJ 1999The role of collagen in the declining mechanical properties of aging human cortical boneJ Biomed Mater Res45108116PubMedCrossRefGoogle Scholar
  17. 17.
    Vashishth, D, Gibson, GJ, Khoury, JI, Schaffler, MB, Kimura, J, Fyhrie, DP 2001Influence of nonenzymatic glycation on biochemical properties of cortical boneBone (NY)28195201Google Scholar
  18. 18.
    Uzawa, K, Grezesik, WJ, Nishimura, T, Kuznetsov, SA, Robey, PG, Brenner, DA, Yamauchi, M 1999Differential expression of human lysyl hydroxylase genes, lysyl hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitroJ Bone Miner Res1412701280CrossRefGoogle Scholar
  19. 19.
    Saito, M, Soshi, S, Fujii, K 2003Effect of hyper- and microgravity on collagen post-translational controls of MC3T3-E1 osteoblastJ Bone Miner Res1816951705PubMedCrossRefGoogle Scholar
  20. 20.
    Smith-Mongo, L, Kagan, HM 1998Lysyl oxidase; properties, regulation and multiple functions in biologyMatrix Biol16387398CrossRefGoogle Scholar
  21. 21.
    Sell, DR, Monnier, VM 1989Structure elucidation of a senescence crosslink from human extracellular matrix: implication of pentoses in the aging processJ Biol Chem2642159721602PubMedGoogle Scholar
  22. 22.
    Miyata, T, Taneda, S, Kawai, R, Ueda, Y, Horiuchi, S, Hara, M, Maeda, K, Monnier, VM 1996Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosisProc Natl Acad Sci U S A9323532358PubMedCrossRefGoogle Scholar
  23. 23.
    Takahashi, M, Oikawa, M, Nagano, A 2000Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end productJ Gerontol A Biol Sci Med Sci55137140Google Scholar
  24. 24.
    Yoshihara, K, Nakamura, K, Kanai, M, Nagayama, Y, Takahashi, S, Saito, N, Nagata, M 1998Determination of urinary and serum pentosidine and its application to elder patientsBiol Pharm Bull2110051008PubMedGoogle Scholar
  25. 25.
    Viguet-Carrin, S, Garnero, P, Delmas, PD 2006The role of collagen in bone strengthOsteoporos Int17319336PubMedCrossRefGoogle Scholar
  26. 26.
    Garnero, P, Borel, O, Gineyts, E, Duboeuf, F, Solberg, H, Bouxsein, ML, Christiansen, C, Delmas, PD 2006Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical boneBone (NY)38300309Google Scholar
  27. 27.
    Viguet-Carrin, S, Roux, JP, Arlot, ME, Merabet, Z, Leeming, DJ, Byrjalsen, I, Delmas, PD, Bouxsein, ML 2006Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebraeBone (NY)3910731079Google Scholar
  28. 28.
    Nishizawa, Y, Nakamura, T, Ohta, H, Kushida, K, Gorai, I, Shiraki, M, Fukunaga, M, Hosoi, T, Miki, T, Chaki, O, Ichimura, S, Nakatsuka, K, Miura, M 2005Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)J Bone Miner Metab2397104PubMedCrossRefGoogle Scholar
  29. 29.
    Yoshihara, K, Nakamura, K, Kanai, M, Nagayama, Y, Takahashi, S, Saito, N, Nagata, M 1998Determination of urinary and serum pentosidine and its application to elder patientsBiol Pharm Bull2110051008PubMedGoogle Scholar
  30. 30.
    Shiraki, M, Shiraki, Y, Aoki, C, Hosoi, T, Inoue, S, Kaneki, M, Ouchi, Y 1997Association of bone mineral density with apolipoprotein E phenotypeJ Bone Miner Res1214381445PubMedCrossRefGoogle Scholar
  31. 31.
    Genant, HK, Jergas, M, Palermo, L, Nevitt, M, Valentin, RS, Black, D, Cummings, SR 1996Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The study of Osteoporotic Fractures Research GroupJ Bone Miner Res11984996PubMedGoogle Scholar
  32. 32.
    Fukunaga, M, Nakamura, T, Shiraki, M, Kuroda, T, Ohta, H, Hosoi, T, Orimo, H 2004Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese womenJ Bone Miner Metab22104110PubMedCrossRefGoogle Scholar
  33. 33.
    Kanis, JA, Borgstrom, F, De Laet, C, Johansson, H, Johnell, O, Jonsson, B, Oden, A, Zethraeus, N, Pfleger, B, Khaltaev, N 2005Assessment of fracture riskOsteoporosis Int16581589CrossRefGoogle Scholar
  34. 34.
    Cummings, SR, Black, DM, Thompson, DE, Applegate, WB, Barrett-Connor, E, Musliner, TA, Palermo, L, Prineas, R, Rubin, SM, Scott, JC, Vogt, T, Wallace, R, Yates, AJ, LaCroix, AZ 1998Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention TrialJAMA28020772082PubMedCrossRefGoogle Scholar
  35. 35.
    Harris, ST, Watts, NB, Genant, HK, McKeever, CD, Hangartner, T, Keller, M, Chesnut, CH,3rd, Brown, J, Eriksen, EF, Hoseyni, MS, Axelrod, DW, Miller, PD 1999Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study GroupJAMA28213441352PubMedCrossRefGoogle Scholar
  36. 36.
    Ettinger, B, Black, DM, Mitlak, BH, Knickerbocker, RK, Nickelsen, T, Genant, HK, Christiansen, C, Delmas, PD, Zanchetta, JR, Stakkestad, J, Gloer, CC, Krueger, K, Cohen, FJ, Eckert, S, Ensrud, KE, Avioli, LV, Lips, P, Cummings, SR 1999Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA282637645PubMedCrossRefGoogle Scholar
  37. 37.
    Saito, M, Fujii, K, Soshi, S, Tanaka, T 2006Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation induced pentosidine in the femoral neck cortex in cases of femoral neck fractureOsteoporosis Int17986995CrossRefGoogle Scholar
  38. 38.
    Katayama, Y, Akatsu, T, Yamamoto, M, Kugai, N, Nagata, N 1996Role of nonenzymatic glycosylation of type I collagen in diabetic osteopeniaJ Bone Miner Res11931937PubMedCrossRefGoogle Scholar
  39. 39.
    Skolnik, EY, Yang, Z, Makita, Z, Radoff, S, Kirstein, M, Vlassara, H 1991Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathyJ Exp Med174931939PubMedCrossRefGoogle Scholar
  40. 40.
    van Meurs, JB, Dhonukshe-Rutten, RA, Pluijm, SM, Van der Klift, M, de Jonge, R, LinDemans, J, De Groot, LC, Hofman, A, Witteman, JC, Van Leeuwen, JP, Breteler, MM, Lips, P, Pols, HA, Uitterlinden, AG 2004Homocysteine levels and the risk of osteoporotic fractureN Engl J Med35020332041PubMedCrossRefGoogle Scholar
  41. 41.
    Takahashi, M, Oikawa, M, Nagano, A 2000Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end productJ Gerontol A Biol Sci Med Sci55M137M140PubMedGoogle Scholar
  42. 42.
    Siris, ES, Miller, PD, Barrett-Connor, E, Faulkner, KG, Wehren, LE, Abbott, TA, Berger, ML, Santora, AC, Sherwood, LM 2001Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk AssessmentJAMA28628152822PubMedCrossRefGoogle Scholar
  43. 43.
    Barrett-Connor, E, Siris, ES, Wehren, LE, Miller, PD, Abbott, TA, Berger, ML, Santora, AC, Sherwood, LM 2005Osteoporosis and fracture risk in women of different ethnic groupsJ Bone Miner Res20185194PubMedCrossRefGoogle Scholar
  44. 44.
    Nelson, HD, Helfand, M, Woolf, SH, Allan, JD 2002Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task ForceAnn Intern Med137529541PubMedGoogle Scholar
  45. 45.
    Delmas, PD van de Langerijt, L Watts, NB Eastell, R Genant, H Grauer, A Cahall, DL IMPACT Study Group2005Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT studyJ Bone Miner Res20557563PubMedCrossRefGoogle Scholar
  46. 46.
    Fujiwara, S, Kasagi, F, Masunari, N, Naito, K, Suzuki, G, Fukunaga, M 2003Fracture prediction from bone mineral density in Japanese men and womenJ Bone Miner Res1815471553PubMedCrossRefGoogle Scholar
  47. 47.
    Gineyts, E, Cloos, PA, Borel, O, Grimaud, L, Delmas, PD, Garnero, P 2000Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnoverBiochem J345481485PubMedCrossRefGoogle Scholar
  48. 48.
    Verzijl, N, DeGroot, J, Thorpe, SR, Bank, RA, Shaw, N, Lyons, TJ, Bijlsma, JWJ, Lafeber, FPJG, Baynes, JW, TeKoppele, JM 2000Effect of collagen turnover on the accumulation of advanced glycation end productsJ Biol Chem2753902739031PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2008

Authors and Affiliations

  • Masataka Shiraki
    • 1
    Email author
  • Tatsuhiko Kuroda
    • 2
  • Shiro Tanaka
    • 3
  • Mitsuru Saito
    • 4
  • Masao Fukunaga
    • 5
  • Toshitaka Nakamura
    • 6
  1. 1.Department of Internal MedicineResearch Institute and Practice for Involutional DiseasesNaganoJapan
  2. 2.Department of Obstetric and GynecologyTokyo Women's Medical UniversityTokyoJapan
  3. 3.Department of Epidemiology and BiostatisticsTokyo UniversityTokyoJapan
  4. 4.Department of Orthopedic SurgeryJikei University School of MedicineTokyoJapan
  5. 5.Department of Nuclear MedicineKawasaki Medical SchoolOkayamaJapan
  6. 6.Department of Orthopedic SurgeryUniversity of Occupational and Environmental HealthFukuokaJapan

Personalised recommendations